Holen Sie sich die Stockscreener-App
0.7405
2.72%
0.0196
Handel nachbörslich:
.74
-0.0005
-0.07%
Invivyd Inc Aktie (IVVD) Neueste Nachrichten
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
Invivyd (IVVD) sees 6.3% ownership reported by Perceptive Advisors group - Stock Titan
Invivyd (IVVD): BVF-led group discloses 29.6M shares, 9.99% beneficial stake - Stock Titan
Invivyd earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Invivyd (NASDAQ:IVVD) Announces Earnings Results, Beats Expectations By $0.01 EPS - marketbeat.com
Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo! Finance Canada
Invivyd, Inc. Q2 2026: Revenue $14.29M, EPS $(0.14) — 10-Q Summary - TradingView
Invivyd (IVVD) widens loss, warns on going concern as cash falls to $160M - Stock Titan
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
BRIEF-Invivyd Q2 EPS USD -0.14 - TradingView
IVVD Q2'26 Earnings: revenue estimate is 14.40M USD - TradingView
Invivyd Insider Purchases Yet To Pay Off Regardless Of Recent Strength - Moomoo
Invivyd, Inc. expected to post a loss of 11 cents a shareEarnings Preview - TradingView
Invivyd Inc (IVVD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Invivyd Inc (IVVD) Stock News Today - TradingKey
Invivyd Inc (IVVD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Invivyd (IVVD) to Release Earnings on Thursday - MarketBeat
Invivyd (IVVD) Gains 7.27% to $0.61, Testing Key Resistance After Volatile SessionInverse ETF Flow - dars.gov.et
Invivyd Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Invivyd Shareholder Action Reminder - TMX Newsfile
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - manilatimes.net
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Invivyd Inc. (IVVD) Climbs 3.92% to $0.57 as Biotech Stock Nears Key Resistance LevelPositive Gamma - dars.gov.et
Invivyd grants 277,500 inducement stock options to new hires at $0.54 exercise price - Bitget
Invivyd, Inc. (NASDAQ:IVVD) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Invivyd Inc (IVVD) Valuation: PE, PB & Fair Value Analysis - TradingKey
BlackRock (NYSE: BLK) discloses 5.5% beneficial stake in Invivyd (IVVD) - Stock Titan
Invivyd Inc (IVVD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Invivyd Inc (IVVD) Cash Flow - TradingKey
Invivyd Market Sentiment - Benzinga España
IVVD|Invivyd Inc|Price:0.604|Chg%:-0.007 - TradingKey
Invivyd Inc (IVVD) Balance Sheet - TradingKey
Invivyd Inc (IVVD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Invivyd Inc (IVVD) Income Statement - TradingKey
Invivyd Inc (IVVD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IVVD|Invivyd Inc|Price:0.659|Chg%:+0.055 - TradingKey
Invivyd Inc (IVVD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IVVD|Invivyd Inc|Price:0.611|Chg%:+0.002 - TradingKey
IVVD|Invivyd Inc|Price:0.728|Chg%:+0.041 - TradingKey
Invivyd Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Invivyd Inc (IVVD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IVVD stock trades around recent lows as Invivyd highlights COVID-19 antibody pipeline - Ad-hoc-news.de
Invivyd Inc. (IVVD) Slides 5.76% as Resistance Holds Near $0.78Moving Average Ribbon - dars.gov.et
Invivyd stock trades around recent lows as investors weigh antibody revenue outlook - Ad-hoc-news.de
Invivyd Inc. (IVVD) Q1 2026 Earnings: EPS Falls Short of Estimates; Stock Edges Up Despite Wider LossEPS Surprise History - dars.gov.et
Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK) - The Globe and Mail
Invivyd Inc updates investors on its antiviral pipeline as Nasdaq-listed biotech advances - AD HOC NEWS
H.C. Wainwright reiterates Invivyd stock rating on regulatory path - Investing.com
H.C. Wainwright reiterates Invivyd stock rating on regulatory path By Investing.com - Investing.com South Africa
Invivyd Inc. (IVVD) Surges Nearly 13% as Bulls Test Key Resistance at $0.99Protective Put - dars.gov.et
Invivyd Inc stock and Covid antibody focus - AD HOC NEWS
IVVD Reiterated by BTIG -- Price Target Maintained at $10.00 - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Healthcare Stocks Decline as Investors Rotate Away From Safety -- Healthcare Roundup - Moomoo
IVVD Stock Drops As PEMGARDA Loses Emergency Authorization In 2027 — Invivyd Eyes Full FDA Approval - Stocktwits
FDA to terminate PEMGARDA emergency authorization in June 2027 - Investing.com UK
Invivyd receives FDA termination notice for PEMGARDA EUA - grafa.com
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):